CureSee
PrivateLast Round
Angel
Feb 16, 2023
Est. Valuation
$600,000
Total Funding Raised
$84,000
Company Overview
CureSee is a health-tech company that provides an AI-based vision therapy software platform for treating conditions such as amblyopia, squint eye, and convergence insufficiency.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Telemedicine, Patient Engagement, Computer Vision, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CureSee Comparables
Compare CureSee with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bynocs | 90% | |
| RevitalVision | 83% | |
| Vivid Vision | 82% | |
CureSee Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Feb 16, 2023 |
Key People
Founding team and executive leadership
CureSee Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ministry of Electronics and Information Technology | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors increased 69% MoM, reaching 14.8K.
- Mar 2, 2026
Monthly visitors increased 207% MoM, reaching 8.7K.
CureSee Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CureSee's valuation, stock price, and market status.